Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 SGD | 0.00% | 0.00% | -20.00% |
Apr. 22 | Megachem Appoints Non-Executive Chairman | MT |
Apr. 19 | Megachem Limited Announces Reconstitution of the Board of Directors and Board Committees | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 42.66 | 39.99 | 43.99 | 55.99 | 67.98 | 66.65 |
Enterprise Value (EV) 1 | 49.7 | 46.17 | 49.54 | 75.79 | 95.14 | 84.41 |
P/E ratio | 10.5 x | 10.4 x | 8.58 x | 7.21 x | 11.6 x | -11.3 x |
Yield | 4.69% | 5% | 4.55% | 4.76% | 3.92% | - |
Capitalization / Revenue | 0.36 x | 0.35 x | 0.42 x | 0.4 x | 0.47 x | 0.54 x |
EV / Revenue | 0.42 x | 0.41 x | 0.47 x | 0.55 x | 0.66 x | 0.69 x |
EV / EBITDA | 8.5 x | 8.96 x | 12.3 x | 9.46 x | 11.8 x | -11.8 x |
EV / FCF | 419 x | 10.1 x | 46.1 x | -5.26 x | -15.8 x | 6.53 x |
FCF Yield | 0.24% | 9.92% | 2.17% | -19% | -6.33% | 15.3% |
Price to Book | 0.9 x | 0.81 x | 0.84 x | 0.98 x | 1.16 x | 1.33 x |
Nbr of stocks (in thousands) | 133,300 | 133,300 | 133,300 | 133,300 | 133,300 | 133,300 |
Reference price 2 | 0.3200 | 0.3000 | 0.3300 | 0.4200 | 0.5100 | 0.5000 |
Announcement Date | 3/21/19 | 3/29/20 | 3/31/21 | 3/31/22 | 3/27/23 | 3/27/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 117.9 | 113.8 | 105.2 | 138.9 | 143.7 | 123 |
EBITDA 1 | 5.85 | 5.151 | 4.018 | 8.015 | 8.068 | -7.138 |
EBIT 1 | 4.938 | 4.286 | 3.131 | 7.249 | 7.131 | -8.152 |
Operating Margin | 4.19% | 3.77% | 2.98% | 5.22% | 4.96% | -6.63% |
Earnings before Tax (EBT) 1 | 5.382 | 4.967 | 5.938 | 9.186 | 7.83 | -5.339 |
Net income 1 | 4.08 | 3.844 | 5.126 | 7.761 | 5.877 | -5.908 |
Net margin | 3.46% | 3.38% | 4.87% | 5.59% | 4.09% | -4.8% |
EPS 2 | 0.0306 | 0.0288 | 0.0385 | 0.0582 | 0.0441 | -0.0443 |
Free Cash Flow 1 | 0.1185 | 4.581 | 1.074 | -14.42 | -6.024 | 12.93 |
FCF margin | 0.1% | 4.03% | 1.02% | -10.38% | -4.19% | 10.51% |
FCF Conversion (EBITDA) | 2.03% | 88.94% | 26.73% | - | - | - |
FCF Conversion (Net income) | 2.9% | 119.19% | 20.96% | - | - | - |
Dividend per Share 2 | 0.0150 | 0.0150 | 0.0150 | 0.0200 | 0.0200 | - |
Announcement Date | 3/21/19 | 3/29/20 | 3/31/21 | 3/31/22 | 3/27/23 | 3/27/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 7.05 | 6.18 | 5.56 | 19.8 | 27.2 | 17.8 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 1.204 x | 1.2 x | 1.383 x | 2.471 x | 3.366 x | -2.488 x |
Free Cash Flow 1 | 0.12 | 4.58 | 1.07 | -14.4 | -6.02 | 12.9 |
ROE (net income / shareholders' equity) | 8.8% | 7.78% | 9.76% | 13.8% | 9.94% | -10.1% |
ROA (Net income/ Total Assets) | 3.82% | 3.19% | 2.21% | 4.48% | 3.91% | -4.69% |
Assets 1 | 106.8 | 120.4 | 232.4 | 173.2 | 150.3 | 126 |
Book Value Per Share 2 | 0.3500 | 0.3700 | 0.3900 | 0.4300 | 0.4400 | 0.3700 |
Cash Flow per Share 2 | 0.0900 | 0.1100 | 0.1200 | 0.0900 | 0.0900 | 0.1000 |
Capex 1 | 0.75 | 0.46 | 2.82 | 3.42 | 1.66 | 1.19 |
Capex / Sales | 0.64% | 0.4% | 2.68% | 2.46% | 1.16% | 0.96% |
Announcement Date | 3/21/19 | 3/29/20 | 3/31/21 | 3/31/22 | 3/27/23 | 3/27/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.00% | 39.13M | |
-0.19% | 74.89B | |
+0.09% | 46.52B | |
-4.19% | 30.82B | |
+10.28% | 18.19B | |
-10.05% | 11.54B | |
+6.39% | 11.24B | |
-8.09% | 9.73B | |
+2.79% | 9.4B | |
+6.33% | 9.37B |
- Stock Market
- Equities
- 5DS Stock
- Financials Megachem Limited